Skip to main content
Top
Published in: Molecular Cancer 1/2022

Open Access 01-12-2022 | Hepatocellular Carcinoma | Editorial Expression of Concern

Editorial expression of concern: Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma

Authors: Fei Wang, Jin-Lian Yang, Ke-ke Yu, Mei Xu, You-zhi Xu, Li Chen, Yan-min Lu, Hao-shu Fang, Xin-yi Wang, Zhong-qian Hu, Fei-fei Li, Lixin Kan, Jia Luo, Si-Ying Wang

Published in: Molecular Cancer | Issue 1/2022

Login to get access

Excerpt

Correction: Mol Cancer 14, 10 (2015)
Metadata
Title
Editorial expression of concern: Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma
Authors
Fei Wang
Jin-Lian Yang
Ke-ke Yu
Mei Xu
You-zhi Xu
Li Chen
Yan-min Lu
Hao-shu Fang
Xin-yi Wang
Zhong-qian Hu
Fei-fei Li
Lixin Kan
Jia Luo
Si-Ying Wang
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2022
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/s12943-022-01693-8

Other articles of this Issue 1/2022

Molecular Cancer 1/2022 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine